MENU

ESPR Esperion Therapeutics Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ESPR is expected to report earnings to fall 77.61% to -7 cents per share on November 05

Esperion Therapeutics ESPR Stock Earnings Reports
Q3'24
Est.
$-0.07
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.29
Q4'23
Missed
by $0.03
Q3'23
Beat
by $0.06
The last earnings report on August 12 showed earnings per share of -33 cents, missing the estimate of -15 cents. With 2.73M shares outstanding, the current market capitalization sits at 495.94M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

ESPR and Stocks

Correlation & Price change

A.I.dvisor tells us that ESPR and CTLT have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESPR and CTLT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESPR
1D Price
Change %
ESPR100%
N/A
CTLT - ESPR
30%
Poorly correlated
-0.43%
RMTI - ESPR
28%
Poorly correlated
+13.29%
ORGO - ESPR
27%
Poorly correlated
-5.21%
SCYX - ESPR
26%
Poorly correlated
-6.16%
EVO - ESPR
26%
Poorly correlated
-8.49%
More

Groups containing ESPR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESPR
1D Price
Change %
ESPR100%
N/A
drugs
theme (265 stocks)
39%
Loosely correlated
+5.37%
biotechnology
theme (248 stocks)
38%
Loosely correlated
+5.56%
biopharmaceuticals
theme (52 stocks)
37%
Loosely correlated
+2.00%
Pharmaceuticals
theme (328 stocks)
18%
Poorly correlated
+0.11%
Pharmaceuticals: Other
theme (252 stocks)
17%
Poorly correlated
+0.05%